Fungiscope - A Global Emerging Fungal Infection Registry (Fungiscope)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01731353|
Recruitment Status : Recruiting
First Posted : November 21, 2012
Last Update Posted : July 19, 2016
|Condition or disease|
|Invasive Fungal Disease|
The specific objectives are:
- To determine the fungal species causing invasive fungal infection in different parts of the world.
- To determine the clinical pattern of disease and document procedures performed for confirmation of the diagnosis.
- To describe the therapeutic regimens used and their efficacy.
- To share clinical isolates among the contributors of Fungiscope.
- To develop molecular biology tools for identification of strains in histopathologically proven invasive fungal infection.
|Study Type :||Observational|
|Estimated Enrollment :||1000 participants|
|Official Title:||Fungiscope - A Global Emerging Fungal Infection Registry|
|Study Start Date :||March 2003|
|Estimated Primary Completion Date :||December 2020|
|Estimated Study Completion Date :||December 2021|
Emerging fungal infections
Web-based registry of invasive infections by emerging fungi
- Treatment efficacy of emerging fungal infections (failure, stable disease, partial response or complete response) [ Time Frame: At 90 days from diagnosis ]
Biospecimen Retention: Samples Without DNA
- fixed tissue
- fungal culture
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01731353
|Contact: Oliver A Cornely, Prof.||+49 221 478 ext firstname.lastname@example.org|
|University Hospital Cologne||Recruiting|
|Cologne, NRW, Germany, 50937|
|Contact: Oliver A Cornely, Prof. +49 221 478 ext 6494 email@example.com|
|Sub-Investigator: Maria JGT Vehreschild, MD|
|Sub-Investigator: Janne Vehreschild, MD|
|Principal Investigator:||Oliver A. Cornely, Professor||University Hospital of Cologne|